We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

The Future of Cellular Immunotherapy: Highly Automated Precision Medicine

Featured Speaker: Matthew Hewitt, PhD, Head of R&D (a.i.) and Clinical Development, Personalized Medicine, Lonza, and Stacey Willard, PhD, Director of Product Management, IsoPlexis

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Learn how our unique technology is playing a critical part in advancing cellular immunotherapy

Discover how IsoPlexis is changing the way cell therapies are developed & manufactured

Review several publications & case studies

Watch the Webinar